The following protein acts cGMP
**Core Concept**
The underlying principle being tested involves the regulation of vascular smooth muscle tone, particularly focusing on the role of **nitric oxide (NO)** and its downstream signaling molecule, **cyclic guanosine monophosphate (cGMP)**. This pathway is crucial for vasodilation.
**Why the Correct Answer is Right**
The correct answer is related to the mechanism by which **cGMP** exerts its effects. **Protein kinase G (PKG)** is the primary target of **cGMP**, activating a cascade that leads to smooth muscle relaxation. This is mediated through the phosphorylation of various proteins, resulting in decreased intracellular **calcium (Ca²⁺)** levels and subsequent vasodilation.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because it does not directly relate to the **cGMP** signaling pathway.
**Option B:** Incorrect as it is not the primary protein that acts downstream of **cGMP** to cause vasodilation.
**Option C:** Incorrect because, although involved in smooth muscle contraction, it is not the direct effector of **cGMP**.
**Clinical Pearl / High-Yield Fact**
Remember, **nitric oxide (NO)** donors like **nitroglycerin** act by increasing **cGMP** levels, leading to vasodilation, which is a key therapeutic effect in treating angina pectoris.
**Correct Answer:** D. Protein Kinase G